The Westaim Corporation has investments in two
high-potential sectors: medical nanotechnology and flat panel
televisions. Westaim's strategy is to maximize return on
investment by partnering with established leaders for effective
market penetration of its businesses.
WED.T: 0.24  +0.00
TODAYS STOCK QUOTE

Our Businesses


NUCRYST
Pharmaceuticals Corp. 
Develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology.

iFire
Technology Ltd. 
Developmental high-performance and low-cost flat panel display technology.

Quick Links

Request Info
View All
Westaim News
May 6, 2008
Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
February 15, 2008
Westaim announces 2007 year-end results
February 11, 2008
Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
Events
May 13, 2008
 Webcast of Annual Meeting of Shareholders
View the live Webcast.
© 2006 The Westaim Corporation Legal
Website Recording by Q4 Web Systems 3.2.6703